Clobromazolam

Phenazolam

Phenazolam

Benzodiazepine designer drug


Phenazolam, (Clobromazolam, DM-II-90, BRN 4550445) is a benzodiazepine derivative which acts as a potent sedative and hypnotic drug. It was first invented in the early 1980s,[1] but was never developed for medical use. It has been sold over the internet as a designer drug, first being identified in seized samples by a laboratory in Sweden in March 2016.[2][3]

Quick Facts Clinical data, Trade names ...

Legality

Clobromazolam was made illegal in Serbia in May 2019,[4] and in Italy in March 2020.[5]

See also


References

  1. Polívka Z, Holubek J, Metyš J, Šedivŷ Z, Protiva M (1983). "Potential hypnotics and anxiolytics: 8-Chloro-6-(2-chlorophenyl)-1-[4-(2-methoxyethyl) piperazino]-methyl-4H-s-triazolo[4,3-a]-1,4-benzodiazepine and related compounds". Collection of Czechoslovak Chemical Communications. 48 (12): 3433–43. doi:10.1135/cccc19833433.
  2. Wagmann L, Manier SK, Felske C, Gampfer TM, Richter MJ, Eckstein N, Meyer MR (October 2020). "Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam". Journal of Analytical Toxicology. 45 (9): 1014–1027. doi:10.1093/jat/bkaa161. PMID 33048135.
  3. ""Службени гласник РС", број 38 од 31. маја 2019" [Rulebook on determining the List of psychoactive controlled substances: 38 / 2019-121] (in Serbian). Serbian Ministry of Health.
  4. "Legislazione - MINISTERO SALUTE - Decreto ministeriale" [Legislation - MINISTRY HEALTH - Ministerial decree] (in Italian). 13 March 2020.

Share this article:

This article uses material from the Wikipedia article Clobromazolam, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.